Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile
scientific article published on 19 November 2013
Author/s
author: Roberto Marasca, Francesco Albano, Francesco Zaja, Francesca Romana Mauro, Marco Vignetti, Agostino Cortelezzi, Robin Foà, Stefano Molica, Maura Brugiatelli, Antonio Cuneo, Caterina Musolino, Alfonso Piciocchi, Irene Della Starza, Marilisa Marinelli, Sabina Chiaretti, Ilaria Del Giudice, Mauro Nanni, Anna Guarini
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.